article thumbnail

Drug Channels News Roundup, February 2021: Accumulator Problems, Humana + ESI, White Bagging Battles, Buy-and-Bill Economics, and Pharmacy Hero Dave Marley

Drug Channels

Approximately one out of four payers strongly agrees that accumulators could have the potential to discourage appropriate utilization of specialty therapies. Such moves would boost profits for PBM-owned specialty pharmacies, which focus primarily on patient-administered products. See page 15 (reproduced below).